ERICA DOUBLEDAY: Open Payments
NPI 1073928511 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,795 in 15 payments from 6 companies in 2025. Trend: 2023 $809 · 2024 $3,157 · 2025 $1,795
Consulting: $900Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 5 | $1,173 |
| Janssen Scientific Affairs, LLC | 5 | $394 |
| Janssen Biotech, Inc. | 1 | $128 |
| ABBVIE INC. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: Orserdu, ERLEADA, RYBREVANT, EPKINLY, KISQALI, ENHERTU.
Industry payments across LA — which companies pay providers there.
